Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

The European League Against Rheumatism recommendations for the management of antineutrophil cytoplasmic antibody-associated vasculitis have been recently published. Unique to recommendation development, they were also voted on by members of a learned society. This paper explores the wider validity o...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, MA, Luqmani, RA, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, KWA, Vaglio, A, Yalçındağ, N, Jayne, DR, Mukhtyar, C
التنسيق:	Journal article
اللغة:	English
منشور في:	BMJ Publishing Group 2017

مواد مشابهة

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
حسب: Yates, M, وآخرون
منشور في: (2016)

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis
حسب: Yates, M, وآخرون
منشور في: (2016)

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS
حسب: Yates, M, وآخرون
منشور في: (2016)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
حسب: Luqmani, R, وآخرون
منشور في: (2007)

Cardiovascular outcomes in ANCA associated vasculitis
حسب: Mukhtyar, C, وآخرون
منشور في: (2008)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
حسب: T. V. Beketova
منشور في: (2017-03-01)

Eular recommendations for vasculitis
حسب: Luqmani, R, وآخرون
منشور في: (2007)

EULAR recommendations for the management of large vessel vasculitis.
حسب: Mukhtyar, C, وآخرون
منشور في: (2009)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
حسب: Jones, R, وآخرون
منشور في: (2010)

EULAR recommendations for the management of primary small and medium vessel vasculitis.
حسب: Mukhtyar, C, وآخرون
منشور في: (2009)

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
حسب: Jones, R, وآخرون
منشور في: (2009)

Comparison of disease activity measures for ANCA-associated vasculitis.
حسب: Merkel, P, وآخرون
منشور في: (2004)

Long-term survival of ANCA-associated vasculitis
حسب: Flossmann, O, وآخرون
منشور في: (2009)

Diagnosis and management of ANCA associated vasculitis.
حسب: Berden, A, وآخرون
منشور في: (2012)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
حسب: Sara Monti, وآخرون
منشور في: (2023-07-01)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
حسب: Mukhtyar, C, وآخرون
منشور في: (2007)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
حسب: Merkel, P, وآخرون
منشور في: (2009)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV
حسب: Sara Monti, وآخرون
منشور في: (2023-06-01)

Long-term patient survival in ANCA-associated vasculitis
حسب: Flossmann, O, وآخرون
منشور في: (2011)

Long-term patient survival in ANCA-associated vasculitis.
حسب: Flossmann, O, وآخرون
منشور في: (2011)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
حسب: Yew, S, وآخرون
منشور في: (2012)

Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis
حسب: Hellmich, B, وآخرون
منشور في: (2006)

Long-term patient survival in ANCA-associated vasculitis.
حسب: Flossmann, O, وآخرون
منشور في: (2011)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
حسب: Hellmich, B, وآخرون
منشور في: (2007)

The prognostic value of BVAS and VDI in ANCA-AAV
حسب: Suppiah, R, وآخرون
منشور في: (2011)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
حسب: Yew, S, وآخرون
منشور في: (2012)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
حسب: Robson, J, وآخرون
منشور في: (2013)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
حسب: T. V. Beketova
منشور في: (2023-10-01)

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.
حسب: Basu, N, وآخرون
منشور في: (2010)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
حسب: Suppiah, R, وآخرون
منشور في: (2011)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
حسب: Robson, J, وآخرون
منشور في: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
حسب: Robson, J, وآخرون
منشور في: (2015)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
حسب: Robson, J, وآخرون
منشور في: (2013)

Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials
حسب: Walsh, M, وآخرون
منشور في: (2009)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
حسب: Dimitrios T Boumpas, وآخرون
منشور في: (2020-09-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
حسب: Walsh, M, وآخرون
منشور في: (2011)

Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study
حسب: David Jayne, وآخرون
منشور في: (2024-07-01)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
حسب: Ntatsaki, E, وآخرون
منشور في: (2014)

Predictors of renal involvement in ANCA associated vasculitis
حسب: Kronbichler, A, وآخرون
منشور في: (2018)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
حسب: N. L. Kozlovskaya, وآخرون
منشور في: (2020-11-01)